Answers are grounded in this paper and cite their sources.
Osteoarthritis (OA) is a degenerative articular disorder manifested by cartilage destruction, subchondral sclerosis, osteophytes, and synovitis, resulting in chronic joint pain and physical disability in the elderly. The purpose of this study was to investigate mitochondrial DNA copy number (mtDNA CN ) and inflammatory cytokines in primary knee OA patients and healthy volunteers. A total of 204 knee OA patients and 169 age-matched healthy volunteers were recruited. Their relative blood leukocyte mtDNA CN was assessed by quantitative real-time polymerase chain reaction (qRT-PCR), and ten inflammatory cytokines in their plasma were detected by multiplex immunoassay. Blood leukocyte mtDNA CN in the OA group was significantly lower than that in the control group. Leukocyte mtDNA CN in the control group was negatively correlated with their age ( r =−0.380, P <0.0001), whereas mtDNA CN in the OA group was positively correlated with their age ( r =0.198, P <0.001). Plasma interleukin-4 (IL-4) and IL-6 were significantly higher in the knee OA group than in the control group. The plasma IL-6 level was positively correlated with blood leukocyte mtDNA CN in the OA group ( r =0.547, P =0.0014). IL-5 showed as a major factor (coefficient 0.69) in the second dimension of principle components analysis (PCA)-transformed data and was significantly higher in the OA group ( P <0.001) as well as negatively correlated with mtDNA CN ( r =−0.577, P <0.001). These findings suggest that elevation of plasma IL-4 and IL-6 and a relative reduction in mtDNA CN might be effective biomarkers for knee OA. IL-5 is a plausible factor responsible for decreasing blood leukocyte mtDNA CN in knee OA patients.
No takes yet. Share an insight, caveat, or question.
Zhan et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: